New medical marijuana uses approved in Connecticut
HARTFORD — Patients with intractable headaches, rheumatoid arthritis and muscular dystrophy will soon be able to treat their ailments with medical marijuana in Connecticut.
The legislature’s Regulation Review Committee unanimously voted Tuesday to expand the approved uses of medical marijuana for palliative care. At the recommendation of the Connecticut Board of Physicians, the new regulation adds eight new conditions that can be treated with medical marijuana in patients 18 and older. Minor patients can now treat muscular dystrophy and a genetic disorder known as brittle bone disease with medical marijuana.
“We’re pleased that the legislature has accepted these regulations, allowing more patients with severe debilitating conditions, including intractable headache syndromes, to have access to this medication,” said Michelle Seagull, commissioner of the Department of Consumer Protection, which oversees the state’s medical marijuana program. “We look forward to serving more patients through the medical marijuana program, and are proud that this medication has been such an effective treatment option for thousands of patients in our state.”
The new regulation will become effective after DCP submits it to the Secretary of the State’s office — likely next week, said state Sen. Paul Doyle, D-Wethersfield, chair of the committee.
firstname.lastname@example.org; Twitter: @emiliemunson